This report analyzes global oncology developments across research, access, and spending. It highlights continued growth in oncology pipelines, particularly targeted therapies, immuno-oncology, and cell and gene therapies. Spending continues to rise but varies widely by region due to access, reimbursement, and infrastructure differences. The report examines clinical trial activity, regulatory approvals, and patient outcomes, noting increasing complexity in treatment pathways. It emphasizes disparities in access to innovation and the need for health system readiness, sustainable financing, and coordinated policy efforts to ensure patients benefit from rapid scientific progress.

Join for free to read